CLINICAL_TRIALS
trial_result
· 2022-03-10
Clinical Trial Update: Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women [Phase 4]
Summary
Phase 4 trial evaluating the effect of intravenous hyoscine butylbromide on labor in high-risk women completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cairo University | Conditions: Vaginal Delivery | Phase 4 | Status: COMPLETED